Last reviewed · How we verify
NCT03750344
ChroniSense Polso Wrist Worn Respiration Rate Validation Study
NA trial testing Diagnostic test in Respiratory Rate in 20 participants. Completed in 30 November 2018.
9 November 2018
Quick facts
| Lead sponsor | ChroniSense Medical Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 20 |
| Start date | 6 November 2018 |
| Primary completion | 9 November 2018 |
| Estimated completion | 30 November 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Diagnostic test
Conditions studied
- Respiratory Rate — all drugs for Respiratory Rate →
Sponsor
ChroniSense Medical Ltd.
Who can join
18 and older, any sex, with Respiratory Rate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
20 volunteer test subjects will be entered into an accuracy study that is designed to validate accuracy of the respiratory rate of the Polso Monitoring system
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03750344
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Diagnostic test
Trials testing the same drug.
- NCT06156813 — Turkish Lower-Extremity Motor Activity Log (LE-MAL) · recruiting
- NCT05506670 — Disease Burden of RSV · NA · completed
- NCT06082908 — Geriatric Syndrome in Nursing Home Residents · completed
- NCT05843851 — Genetic Newborn Screening for Cystinosis and Primary Hyperoxaluria · NA · recruiting
- NCT06331117 — Effect of RAS/MAPK Pathway Hyperactivation on Growth' and Bone' Profile of the RASopathies · NA · recruiting
Other recruiting trials for Respiratory Rate
Currently open trials in the same condition.
- NCT05451875 — Validation of Vital Signs Recording With VT-Patch Connected Devices in Children · recruiting
- NCT05022264 — Remote Investigation and Assessment of Vital Signs · recruiting
- NCT03750318 — Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital · NA · active not recruiting
Other ChroniSense Medical Ltd. trials
Trials by the same sponsor.
- NCT05735210 — Polso™ Watch Blood Pressure Accuracy With Blood Pressure Change Validation · NA · unknown
- NCT05246358 — Respiratory Rate Validation Study - ChroniSense Polso · NA · completed
- NCT03735329 — Polso SpO2 Accuracy Validation Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03750344 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ChroniSense Medical Ltd.
- Last refreshed: 5 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03750344.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing